WINT (Windtree Therapeutics Inc.) Bathi saben saham sajrone patang kuartal pungkasan

Liquidity shortages and the risk of share dilution are putting pressure on Windtree Therapeutics (WINT). Reviewing the chart on GURU.Markets, we see that the current EPS YoY TTM growth rate of 73.30 reflects recent values. A diversified small-molecule portfolio reduces FDA regulatory barriers, yet the fierce competition for cardiology drug efficacy in this niche remains a serious challenge for the business.

Windtree - Bathi resik saben saham (EPS TTM) WINT (periode 11.02.2024 - 20.02.2024)

Rincian metrik keuangan lan pasar Windtree (WINT)

- rega saham lan konsensus proyeksi valuasi:

Kurs saham Windtree Therapeutics|WINT - Target konsensus

- indikator valuasi pasar bisnis:

Nilai pasar Windtree Therapeutics Inc.|WINT - Nilai Total Perusahaan

- rincian valuasi buku bisnis:

Nilai Akuntansi Saham Windtree Therapeutics|WINT - Kapitalisasi Buku|Koefisien Nilai Pasar marang Nilai Buku windtreetx.com|WINT - Total Aset Perusahaan

- data utang lan likuiditas:

Utang marang Modal Windtree Therapeutics|WINT - Rasio utang jangka dawa marang ekuitas|Rasio tanggungan utang jangka cendhak marang modal Windtree Therapeutics|WINT - Gunggung utang perusahaan|Utang marang modal buku Windtree Therapeutics Inc.|WINT - Utang jangka dawa perusahaan|Silihan lan utang jangka cendhak perusahaan Windtree Therapeutics|Likuiditas darurat windtreetx.com

- rincian asil keuangan lan kelipatan valuasi:

WINT - Bathi resik perusahaan|Penghasilan resik sing dikarepake Windtree Therapeutics|WINT - Pangali P/E|Pangali Forward P/E Windtree Therapeutics|WINT - Rasio rega marang bathi tumrap wutah|Rasio nilai perusahaan marang bathi operasional sadurunge panyusutan Windtree Therapeutics Inc.|WINT - Bathi operasional EBITDA|Bathi resik saben siji saham sajrone rolas wulan pungkasan Windtree Therapeutics|WINT - Bathi resik saben saham sajrone 12 wulan pungkasan|Wutah bathi EPS kuartalan windtreetx.com|WINT - Wutah bathi resik saben saham ing taun iki|Proyeksi tambahing bathi saben saham ing taun ngarep Windtree Therapeutics

- indikator dodolan lan pendapatan:

WINT - Pendapatan lan volume dodolan|Dodolan mangsa ngarep perusahaan Windtree Therapeutics|WINT - Multiplikator P/S|Multiplikator forward rega marang pendapatan Windtree Therapeutics Inc.

Pambiji fundamental:Windtree Therapeutics, Inc. (WINT)

Windtree Therapeutics focuses on developing bioengineered products for heart tissue regeneration. The EPS YoY TTM percentage trend reflects the annual growth rate of net income per share, recalculated based on the latest 10-Q reports. This indicator allows for tracking the actual business trajectory by excluding random fluctuations. Sharp peaks on the chart often reflect inflated market expectations, increasing the risk of a correction. Stable growth of this metric confirms the effectiveness of the company's R&D strategy.

Analisis pesaing Windtree Therapeutics